Which hedge funds own ENOV? ENOVIS CORPORATION, Q2 2026 13F holders
Healthcare · Open on the interactive board
9 of the hedge funds tracked by WhaleCreep disclosed a position in ENOV (ENOVIS CORPORATION) in their Q2 2026 13F filings, worth $108.5m in total. The largest holder by portfolio weight is Rubric Capital Management at 0.7% of its book. 1 exited: Woodline Partners.
9tracked managers holding
0opened this quarter
1exited this quarter
Which hedge funds hold ENOV? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Rubric Capital Management | Q2 2026 | 0.7% | $80.7m | 3,900,000 | 59% | added |
| Southeastern Asset Management | Q2 2026 | 0.2% | $916.1k | 44,258 | 0% | held |
| Millennium Management | Q2 2026 | 0.0% | $16.6m | 803,315 | 28% | added |
| Bridgewater Associates | Q2 2026 | 0.0% | $1.6m | 77,088 | 50% | added |
| Marshall Wace | Q2 2026 | 0.0% | $6.1m | 294,445 | 13% | added |
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $308.2k | 14,891 | -4% | reduced |
| Tudor Investment | Q2 2026 | 0.0% | $521.0k | 25,167 | -83% | reduced |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $1.7m | 83,796 | -18% | reduced |
| Ancora Advisors | Q2 2026 | 0.0% | $7.9k | 337,144 | -6% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Woodline Partners | 0.3% | $8.3m |
Held in a manager's last filing on record
These managers have not filed for the latest quarter; their last disclosure is dated.
| Manager | Last filing | Weight |
|---|---|---|
| Cove Street Capital | Q3 2025 | 1.8% |
How has hedge fund ownership of ENOV changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 9 | $108.5m |
| Q1 2026 | 11 | $110.4m |
| Q4 2025 | 5 | $77.2m |
| Q3 2025 | 8 | $104.5m |
| Q2 2025 | 7 | $34.3m |
| Q1 2025 | 6 | $36.1m |
| Q4 2024 | 7 | $26.0m |
| Q3 2024 | 7 | $31.5m |
| Q2 2024 | 8 | $24.3m |
| Q1 2024 | 9 | $28.7m |
| Q4 2023 | 9 | $30.6m |
| Q3 2023 | 7 | $59.8m |
| Q2 2023 | 7 | $139.4m |
| Q1 2023 | 10 | $196.9m |
| Q4 2022 | 12 | $269.1m |
| Q3 2022 | 12 | $269.1m |
Counts every tracked manager that disclosed ENOV in that quarter's filing, including managers that have since stopped filing.